Founded on May 6, 2019, Artemis DNA is a full service, Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, high-complexity clinical diagnostic laboratory company that provides proprietary Next Generation Sequencing (NGS) genetic testing and diagnostic laboratory services for a wide variety of medical specialties, including cardiology, oncology, immunology, neurology, reproductive health and pharmacogenomics.
Artemis DNA’s testing enhances the delivery of “personalized medicine” by assessing a patient’s own genetic makeup and clinical characteristics which allows for informed decision making in prevention and treatment choices. Artemis DNA also provides pre- and post-testing genetic education and counseling services, as well as conducting research and development to discover and develop additional novel diagnostic services.
Artemis is the Greek Goddess of the hunt, who is also the twin sister of Apollo, the Greek God of medicine. The shift to change our name to Artemis DNA, effective May 1, 2021, is to create a presence as well as disruption to the genomics industry. The name Artemis DNA aligns with our company vision of women empowerment and genetics. We will save lives across all populations through providing accessibility to testing and education programs, advocating cancer prevention and early detection and empowering everyone to take charge of their own health and well-being.
Birthing from the shift is also Artemis DNA Foundation, a non-profit organization with the goal to provide free breast cancer screening to women to 3rd world country.
Making actionable genetic findings accessible to all people to facilitate the early detection and prevention of disease.
Improve the overall health of the population, one family at a time.
MWF (Make Work Fun)
Sense of Urgency
“It’s in Our Genes”